Clinical Trial Update: Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a combination therapy (HAIC with HLX10 and HLX04) for hepatocellular carcinoma with major portal vein thrombosis; status no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma with Major Portal Vein Thrombosis

Drugs mentioned

• HAIC (hepatic artery infusion chemotherapy)
• HLX04 (HLX04)
• HLX10

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Carcinoma With Major Portal Vein Thrombosis | Phase 2 | Status: UNKNOWN